According to a systematic review and meta-analysis by Lin et al. (2013), the sensitivity and specificity of HE4 in detecting epithelial malignant ovarian tumors were 74% and 87%, respectively, and 80% and 75%, respectively, for borderline tumors. This evidence concerns the gene WFDC2 and malignant epithelial tumor of ovary.